FDA

News

HHS staffers wait for news after government shutdown

The US government has shut down after Republicans and Democrats failed to resolve a budget standoff and the federal government ran out of money.

News

FDA will review abortion pill safety – will it be impartial?

The Trump administration's linking of autism to Tylenol and vaccines with no evidence raises concern about an FDA review of mifepristone's safety.

Sales & Marketing

What can FDA really do about DTC pharma advertising?

What legal hurdles does the FDA face in changing the rules for broadcast advertising? And what should the industry be doing to prepare for changes?

News

Flood of warning letters follows DTC ad clampdown

The FDA has lost no time following through on its plan to tighten up DTC advertising of medicines, sending out dozens of untitled and warning letters.

News

FDA's Makary explains 'overdue' pharma ads crackdown

FDA Commissioner Marty Makary has called DTC ads for medicines a "public health crisis" as the industry prepares for a regulatory crackdown.

News

HHS, FDA drop major DTC advertising policy changes

HHS and FDA announced a new policy change that would require pharma companies to list drug information much more extensively in broadcast ads.

HHS staffers wait for news after government shutdown

FDA will review abortion pill safety – will it be impartial?

What can FDA really do about DTC pharma advertising?

Flood of warning letters follows DTC ad clampdown

FDA's Makary explains 'overdue' pharma ads crackdown

HHS, FDA drop major DTC advertising policy changes

Lilly's 'triple G' retatrutide aces crucial obesity trial

Discover a new era of healthcare panel engagement: Grounded ...

FDA

Editor's Picks